Senior Scientist, Analytical Development

• Lead analytical method development, method implementation, product characterization and analytical control strategy development for pre-clinical and clinical stage development programs
• Provide timely technical support and daily management of outsourced drug substance and drug product analytical activities with external partners, including in-process, release and stability testing
• Design and support analytical method transfer and validation activities across a portfolio of small molecule, solid oral dosage projects.
• Lead laboratory investigations to determine root cause and implement corrective actions as needed
• Collaborate with various CMC functions and CMC leadership to develop analytical strategies and deliver on key objectives
• Author and review drug substance and drug product analytical sections for regulatory submissions
• Present to cross functional teams and effectively communicate critical analytical issues and solutions
• Stay current with emerging technologies and industry trends to support Analytical Development
• Perform other duties as assigned

The Senior Scientist position within Analytical Development leads small molecule analytical activities within a growing, dynamic Pharmaceutical Development organization. They will collaborate with cross-functional teams on analytical method development, molecule characterization, testing and analysis throughout various stages of drug development. They will perform internal laboratory work as well as manage external partners for method development, validation, and analytical testing, including stability program design and execution. The successful candidate will thrive in a highly collaborative matrix team environment to ensure the successful development of new drugs.

Why join Team Alkermes?

Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.

We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts' Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.